Pioneer Surgical
Technology, Inc., a leading innovator in the design and manufacture of spinal
and orthopaedic implants, instruments and biologic products, today announced
that it has won the prestigious Frost + Sullivan 2009 North American Technology
Innovation of the Year Award for the E-Matrix(TM) Tissue Scaffold, recently
launched in the United States.
The patented E-Matrix technology provides a bioscaffold for leading edge biologic
products in orthopaedics and other therapeutic areas. Pioneer's CEO and President,
Jeff Millin, noted, "This award reflects Pioneer's commitment to deliver
on innovation that benefits patients and surgeons, and is cost-effective for
the healthcare system." E-Matrix is the result of over ten years of dedicated
research and development.
Ronald S. Hill, PhD, Vice President of Research and Development, says, "Frost
& Sullivan is world renowned for technology analysis and after an exhaustive
review of products in this therapeutic category, Pioneer has been recognized
for the significance and potential of this innovative technology to become the
market leader."
Pioneer continues to focus on commercializing these novel technologies and
recently launched a bone graft substitute to the US orthopaedic market utilizing
the E-Matrix(TM) bioscaffold combined with nanOss(TM), a proprietary nano-crystalline
hydroxyapatite.